Structure-activity relationships of substituted benzothiophene-anthranilamide factor Xa inhibitors (Q44301673)

1 December 2017

title

Structure-activity relationships of substituted benzothiophene-anthranilamide factor Xa inhibitors (English)

1 reference

1 December 2017

Yuo-Ling Chou

1

1 reference

1 December 2017

David D Davey

2

1 reference

1 December 2017

Keith A Eagen

3

1 reference

1 December 2017

Brian D Griedel

4

1 reference

1 December 2017

Rushad Karanjawala

5

1 reference

1 December 2017

Gary B Phillips

6

1 reference

1 December 2017

Karna L Sacchi

7

1 reference

1 December 2017

Kenneth J Shaw

8

1 reference

1 December 2017

Shung C Wu

9

1 reference

1 December 2017

Dao Lentz

10

1 reference

1 December 2017

Amy M Liang

11

1 reference

1 December 2017

Lan Trinh

12

1 reference

1 December 2017

Michael M Morrissey

13

1 reference

1 December 2017

Monica J Kochanny

14

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

Bioorganic & Medicinal Chemistry Letters

1 December 2017

published in

1 reference

1 December 2017

volume

13

1 reference

1 December 2017

issue

3

1 reference

1 December 2017

page(s)

507-511

1 reference

Components and assembly of the factor X activating complex

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900938-1

7 January 2021

Perspectives on factor Xa inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900938-1

7 January 2021

New advances in the discovery of thrombin and factor Xa inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900938-1

7 January 2021

Neutral inhibitors of the serine protease factor Xa.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900938-1

7 January 2021

1,2-Dibenzamidobenzene inhibitors of human factor Xa.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900938-1

7 January 2021

N(2)-Aroylanthranilamide inhibitors of human factor Xa

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900938-1

7 January 2021

Non-amidine-containing 1,2-dibenzamidobenzene inhibitors of human factor Xa with potent anticoagulant and antithrombotic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900938-1

7 January 2021

Potent noncovalent thrombin inhibitors that utilize the unique amino acid D-dicyclohexylalanine in the P3 position. Implications on oral bioavailability and antithrombotic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900938-1

7 January 2021

28 Assay of coagulation proteases using peptide chromogenic and fluorogenic substrates

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900938-1

7 January 2021

Tick anticoagulant peptide: kinetic analysis of the recombinant inhibitor with blood coagulation factor Xa.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900938-1

7 January 2021

Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900938-1

7 January 2021

10.1016/S0960-894X(02)00938-1

Identifiers

DOI

1 reference

1 December 2017

1 reference